Literature DB >> 17891536

Why healthy subjects volunteer for phase I studies and how they perceive their participation?

Luis Almeida1, Benedita Azevedo, Teresa Nunes, Manuel Vaz-da-Silva, Patrício Soares-da-Silva.   

Abstract

OBJECTIVE: To characterize the motivations and attitudes of healthy subjects who volunteer for phase I studies as well as their perception of the informed consent procedure and participation in the study.
METHODS: Subjects (n = 136, 48.5/51.5% males/females, 26.9 +/- 5.5 years; 51.9% students, 42.2% employed, 5.9% unemployed) anonymously answered questionnaires regarding study participation and personality (Revised NEO Personality Inventory).
RESULTS: Financial reward was the most important motivation and was most valued by subjects with a lower monthly income (p < 0.01) and lower education (p < 0.05). Personality traits correlated differently with the various motivators for participation. "Word-of-mouth" (mainly by ex-participants) was the source of information on the phase I study for 94.9% of the participants. Most (88.2%) subjects consulted other people (family member/partner, 53.3% of participants; friends, 40.0%; physician, 25.0%) before deciding to participate. In 80% of the cases, the people consulted recommended that the subject not participate, with the risk of serious complications being the main objection in 75.7% cases. The information provided was generally assessed favorably; 34.6% of subjects considered the discomfort caused by participation to be less than that originally reported during the consent procedure, 58.8% considered it to be identical and 6.6% considered it to be higher. Most of the subjects (81.6%) declared that they never felt at risk of a serious complication during their participation in the study, 16.2% occasionally felt that they were at risk and 2.2% felt that they were at risk for a significant period of time. Personality traits correlated with the decision to ask someone else's opinion, the manner in which information provided was rated and the perception of the risk taken during participation.
CONCLUSION: Financial reward as the main motivator for participation in phase I studies was less valued by healthy volunteers with a higher income and education. A subject's motivations and perceptions toward participation were found to be influenced by individual characteristics, including some personality traits.

Entities:  

Mesh:

Year:  2007        PMID: 17891536     DOI: 10.1007/s00228-007-0368-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  What's the price of a research subject? Approaches to payment for research participation.

Authors:  N Dickert; C Grady
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

2.  The research subject as entrepreneur.

Authors:  J A Anderson; C Weijer
Journal:  Am J Bioeth       Date:  2001       Impact factor: 11.229

3.  Drug trials on healthy volunteers in Yugoslavia.

Authors:  R Vrhovac; I Francetić; K Rotim
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-09

4.  Healthy participants in phase I clinical trials: the quality of their decision to take part.

Authors:  Cheryl Rabin; Nili Tabak
Journal:  J Clin Nurs       Date:  2006-08       Impact factor: 3.036

5.  An alternative "description of personality": the big-five factor structure.

Authors:  L R Goldberg
Journal:  J Pers Soc Psychol       Date:  1990-12

6.  Motivations for volunteering as research subjects.

Authors:  E Novak; C E Seckman; R D Stewart
Journal:  J Clin Pharmacol       Date:  1977-07       Impact factor: 3.126

7.  Human subjects in clinical research-a report of three studies.

Authors:  D C Martin; J D Arnold; T F Zimmerman; R H Richart
Journal:  N Engl J Med       Date:  1968-12-26       Impact factor: 91.245

8.  Motivations and rewards for volunteering to be an experimental subject.

Authors:  F J Ayd; P Calabresi
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

9.  Motives and perception of healthy volunteers who participate in experiments.

Authors:  C E van Gelderen; T J Savelkoul; W van Dokkum; J Meulenbelt
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Paying research subjects: participants' perspectives.

Authors:  M L Russell; D G Moralejo; E D Burgess
Journal:  J Med Ethics       Date:  2000-04       Impact factor: 2.903

View more
  29 in total

1.  Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial.

Authors:  Quarraisha Abdool Karim; Ayesha B M Kharsany; Kasavan Naidoo; Nonhlanhla Yende; Tanuja Gengiah; Zaheen Omar; Natasha Arulappan; Koleka P Mlisana; Londiwe R Luthuli; Salim S Abdool Karim
Journal:  Contemp Clin Trials       Date:  2011-01-26       Impact factor: 2.226

2.  Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.

Authors:  Matt Lamkin; Carl Elliott
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

3.  Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.

Authors:  Flavia M Facio; Stephanie Brooks; Johanna Loewenstein; Susannah Green; Leslie G Biesecker; Barbara B Biesecker
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

4.  Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.

Authors:  Heather B Edelblute; Jill A Fisher
Journal:  J Empir Res Hum Res Ethics       Date:  2015-01-20       Impact factor: 1.742

5.  Investigating the informed consent process, therapeutic misconception and motivations of Egyptian research participants: a qualitative pilot study.

Authors:  H Mansour; N Zaki; R Abdelhai; N Sabry; H Silverman; S S El-Kamary
Journal:  East Mediterr Health J       Date:  2015-05-19       Impact factor: 1.628

Review 6.  More than the money: a review of the literature examining healthy volunteer motivations.

Authors:  Leanne Stunkel; Christine Grady
Journal:  Contemp Clin Trials       Date:  2010-12-10       Impact factor: 2.226

7.  A national registry for healthy volunteers in phase 1 clinical trials.

Authors:  David B Resnik; Greg Koski
Journal:  JAMA       Date:  2011-03-15       Impact factor: 56.272

8.  Going the distance: overcoming challenges in recruitment and retention of Black and White women in multisite, longitudinal study of predictors of coronary heart disease.

Authors:  Jean C McSweeney; Christina M Pettey; Ellen P Fischer; Alisa Spellman
Journal:  Res Gerontol Nurs       Date:  2009-10-27       Impact factor: 1.571

9.  Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.

Authors:  Jill A Fisher; Lisa McManus; Megan M Wood; Marci D Cottingham; Julianne M Kalbaugh; Torin Monahan; Rebecca L Walker
Journal:  J Empir Res Hum Res Ethics       Date:  2018-10-08       Impact factor: 1.742

10.  Phase 1 healthy volunteer willingness to participate and enrollment preferences.

Authors:  Stephanie C Chen; Ninet Sinaii; Gabriella Bedarida; Mark A Gregorio; Ezekiel Emanuel; Christine Grady
Journal:  Clin Trials       Date:  2017-08-02       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.